Considering that TCF7L2 is involved in β-cell dysfunction including impaired insulin secretion and disturbed incretin effects as well as an enhanced rate of basal hepatic glucose production [3–7], changes of subsets of metabolites may provide novel insights into biochemical pathways involved in the development of T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.